Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2011
Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasisDimple Chakravarty, Sudipa Saha Roy, Challa Ram Babu, et al.
Cancer Immunology Research|October 5, 2021
γδ T Cells Support Antigen-Specific αβ T cell-Mediated Antitumor Responses during BCG Treatment for Bladder CancerNiannian Ji, Neelam Mukherjee, Zhen-Ju Shu, et al.
Signal Transduction and Targeted Therapy|August 12, 2017
Tumor cell-intrinsic PD-L1 promotes tumor-initiating cell generation and functions in melanoma and ovarian cancerHarshita B Gupta, Curtis A Clark, Bin Yuan, et al.
International Journal of Molecular Sciences|May 14, 2022
Pharmacologic Tumor PDL1 Depletion with Cefepime or Ceftazidime Promotes DNA Damage and Sensitivity to DNA-Damaging AgentsClare Murray, Eva Galvan, Carlos Ontiveros, et al.
Cancer Research|August 18, 2004
Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancerTyler J Curiel, Pui Cheng, Peter Mottram, et al.
Cancer Research|July 21, 2018
Oncogenic BRAFV600E Governs Regulatory T-cell Recruitment during Melanoma TumorigenesisTamer B Shabaneh, Aleksey K Molodtsov, Shannon M Steinberg, et al.
Cancer Immunology, Immunotherapy : CII|June 24, 2022
Selective delipidation of Mycobacterium bovis BCG retains antitumor efficacy against non-muscle invasive bladder cancerNiannian Ji, Meijun Long, Andreu Garcia-Vilanova, et al.
Experimental Gerontology|January 13, 2018
Age effects of distinct immune checkpoint blockade treatments in a mouse melanoma modelÁlvaro Padrón, Vincent Hurez, Harshita B Gupta, et al.
The Journal of Biological Chemistry|January 5, 2018
Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in miceXiujie Sun, Kshama Gupta, Bogang Wu, et al.
Journal for Immunotherapy of Cancer|March 3, 2021
Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind studyNiannian Ji, Neelam Mukherjee, Ryan M Reyes, et al.
Pageof 12